🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — November 2025 Page 6

MASH prevalence in GLP-1 users — November 2025

tampaLisa73 Wed, Jun 4, 2025 at 3:50 AM 44 replies 2,251 viewsPage 6 of 9
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Jun 9, 2025 at 11:45 AM#26
NicoleRaleigh said:
Worth stating the units and the reference range whenever you post a number here.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

35 8Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 32 others
Reply Quote Save Share Report
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Jun 9, 2025 at 10:09 PM#27
NicoleRaleigh said:
Worth stating the units and the reference range whenever you post a number here.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Adding it to my notes with a link back to this thread.

36 9VanRx_Mike, steve_okc, dave_SLC and 33 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Jun 10, 2025 at 8:32 AM#28

Clinical perspective, offered as context rather than as advice. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Happy to go further on any of that.

37 10PharmD_Rodriguez, julia.endo, JessicaM_2024 and 34 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
SkepticalSean
Member
98
345
Jan 2025
Maine
Jun 10, 2025 at 6:55 PM#29
andrew_nyc said:
It helps to say which part of this you are uncertain about.

This matches mine closely enough to be worth saying so out loud. The detail I would add is minor and it is already implied above.

Last edited: Jun 10, 2025 at 10:55 PM
38 11tammy_FL, Dr.LipidDallas, alex_tucson and 35 others
Reply Quote Save Share Report
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Jun 11, 2025 at 5:18 AM#30

OP back with an update, since a thread like this is useless without one.

Following up because I said I would. I changed one thing, left everything else alone, and waited the full interval before looking. It resolved, and I cannot prove which half of that did it.

10 8TomFromTexas, mike.trainer_LA, sarah_nash92 and 7 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register